Robert J Bloch Selected Research

Muscular Diseases (Myopathy)

1/2021	Biomechanical Properties of the Sarcolemma and Costameres of Skeletal Muscle Lacking Desmin.
1/2018	Absence of synemin in mice causes structural and functional abnormalities in heart.
6/2015	Myofiber damage precedes macrophage infiltration after in vivo injury in dysferlin-deficient A/J mouse skeletal muscle.
12/2013	Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane.
1/2012	Distinct effects of contraction-induced injury in vivo on four different murine models of dysferlinopathy.
10/2009	Muscle giants: molecular scaffolds in sarcomerogenesis.
11/2007	Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization.
6/2007	Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy.
8/2005	Postnatal changes in sarcolemmal organization in the mdx mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Bloch Research Topics

Disease

10	Muscular Dystrophies (Muscular Dystrophy) 12/2020 - 11/2004
9	Muscular Diseases (Myopathy) 01/2021 - 08/2005
6	Miyoshi myopathy 01/2022 - 11/2009
6	Necrosis 01/2018 - 10/2008
5	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2022 - 11/2009
4	Inflammation (Inflammations) 06/2015 - 02/2010
3	Facioscapulohumeral Muscular Dystrophy 12/2020 - 06/2007
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2020 - 06/2014
2	type 2B Limb-girdle muscular dystrophy 01/2014 - 01/2012
2	Wounds and Injuries (Trauma) 02/2010 - 09/2009
1	Left Ventricular Dysfunction 01/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018
1	Metabolic Bone Diseases (Osteopenia) 12/2016
1	Dysferlinopathy 01/2014
1	Wasting Syndrome (Wasting Disease) 11/2011
1	Infections 08/2010
1	Restrictive Cardiomyopathy 03/2007
1	Heart Failure 03/2007

Drug/Important Bio-Agent (IBA)

12	DysferlinIBA 01/2022 - 10/2008
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2007
5	DystrophinIBA 01/2018 - 11/2004
2	desmuslin (synemin)IBA 01/2018 - 12/2016
2	fluorescein-dextranIBA 02/2010 - 10/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	DesminIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2018
1	Sarcoglycans (beta Sarcoglycan)IBA 01/2018
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	CardiotoxinsIBA 01/2016
1	CytokinesIBA 06/2015
1	UtrophinIBA 06/2014
1	CalciumIBA 01/2014
1	Diltiazem (Cardizem)FDA LinkGeneric 12/2013
1	Phosphates (Orthophosphate)IBA 08/2010
1	Hormones (Hormone)IBA 08/2010
1	Dopamine (Intropin)FDA LinkGeneric 08/2010
1	Dextrans (Dextran)FDA Link 02/2010
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 02/2010
1	Rho Guanine Nucleotide Exchange FactorsIBA 09/2009
1	Keratin-19 (Keratin 19)IBA 11/2007
1	mu-CrystallinsIBA 06/2007
1	Connexin 43 (Connexin43)IBA 03/2007
1	JNK Mitogen-Activated Protein KinasesIBA 03/2007
1	Biological ProductsIBA 12/2005
1	Dystroglycans (Dystroglycan)IBA 11/2004
1	LigandsIBA 11/2004

Therapy/Procedure

2	Therapeutics 12/2020 - 12/2005
1	Heterologous Transplantation (Xenotransplantation) 12/2020
1	Euthanasia (Mercy Killing) 01/2018